Non-Newtonian Fluids: Solid Under Pressure, Liquid When Gentle

A new peptide drug causes major weight loss in phase 3 clinical study. Brief overview of what it is, what was observed in the clinical study, the risks, and what remains unknown. And, how I think about weighing those unknowns. (Note that “Ozempic” = “Wegovy” = “semaglutide.) #science #reta #peptide

Transmission Fluid Change at 190k Miles | Sister's First Car